Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2003
10/09/2003US20030191076 Induction of immunology response; transgenic plant; measles
10/09/2003US20030191073 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
10/09/2003US20030191063 Peptide selection method
10/09/2003US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190705 Method of humanizing immune system molecules
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190685 Bind to Tumor Necrosis Factor(TNF)-Related Apoptosis Inducing Ligand (TRAIL) receptors ; used in the prevention and treatment of cancers and other proliferative disorders
10/09/2003US20030190676 In which covalently modified antibody takes on the binding specificity of a targeting agent
10/09/2003US20030190668 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190667 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190666 Involves nucleic acids extracted from nematode or arthropod pests which encode P- glycoprotein homologs and regulate resistance to the macrocyclic lactones; enhancing the efficacy of the lactones using multidrug resistant reversing agents
10/09/2003US20030190651 Preventing, ameliorating, correcting dysfunctions or diseases such as cancer, peripheral and central nervous system diseases, and chronic obstructive pulmonary disease
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs)
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190606 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds
10/09/2003US20030190333 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
10/09/2003US20030190332 Engineered viral particle containing a group of co-expressed viral proteins or portions expressed in an edible plant material, adminstering such plant material containing viral vaccine to the gastrointenial mucosa of the patient
10/09/2003US20030190331 Vaccine composition and stabilisation method
10/09/2003US20030190330 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis
10/09/2003US20030190329 Coxsackievirus vectors and their use in prevention and treatment of disease
10/09/2003US20030190328 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
10/09/2003US20030190326 Pharmaceutical composition for immunisation against aids
10/09/2003US20030190324 Immunologically significant herpes simplex virus antigens and methods for using same
10/09/2003US20030190323 Preparations and methods for the treatment of T cell mediated diseases
10/09/2003US20030190322 Immunostimulating properties of a fragment of tgf-beta
10/09/2003US20030190320 Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins
10/09/2003US20030190316 Comprises humanized anti-interleukin-6 receptor antibody in glycine and/or histidine buffer
10/09/2003US20030190315 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines
10/09/2003US20030190314 Administering spray dried plasma for modulating immunoglobulin levels; vaccines; for weight gain; autoimmune disorders
10/09/2003US20030190311 Immunoglobulins; fusion proteins; vaccines
10/09/2003US20030190308 DNA vaccines (gag proteins, nef proteins) for prophylaxis and treatment of HIV infections; drug delivery
10/09/2003US20030190286 Propellant free buccal spray composition for transmucosal administration of pharmacologically active compound comprising 0.001-60 percent by weight immunosuppressants, mucolytics, glucocorticoids and 30-99 percent polar solvent
10/09/2003US20030190285 Having nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions and derivatives thereof; diagnostic and therapeutic applications
10/09/2003US20030188740 Method for production of enhanced traceable immunizing drinking water and other liquid and gas products, devices for production and use thereof, and use of the enhanced products for immunizing living beings
10/09/2003CA2481304A1 Method for treating cancer in humans
10/09/2003CA2481232A1 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003CA2481107A1 Protein-based streptococcus pneumoniae vaccines
10/09/2003CA2480690A1 Combined dna/protein vaccine compositions
10/09/2003CA2480682A1 Nucleic acid sequence and protein, and polypeptides encoding mannitol dehydrogenases or parts thereof, and their preparation and use in diagnostics and therapy
10/09/2003CA2480634A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003CA2480494A1 Synthetic active peptide fragments
10/09/2003CA2480265A1 Cochleates made with purified soy phosphatidylserine
10/09/2003CA2480263A1 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
10/09/2003CA2480128A1 Methods of using flt3-ligand in immunization protocols
10/09/2003CA2480119A1 Cripto-specific antibodies
10/09/2003CA2479920A1 Microgel particles for the delivery of bioactive materials
10/09/2003CA2475202A1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof
10/08/2003EP1350847A1 Human glioma antigen and process for preparing the same
10/08/2003EP1350840A1 Adaptation sites of PRRSV
10/08/2003EP1350839A1 Identification of virulence associated regions RD1 and RD5 enabling the development of improved vaccines of M. bovis BCG and M. microti
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350798A1 Allergenic protein HEV b III of natural rubber latex, its production and use in assays
10/08/2003EP1350797A1 Allergenic protein Hev b II of natural rubber latex, its production and use in assays
10/08/2003EP1350796A1 Attenuated gram negative bacteria
10/08/2003EP1350523A2 Therapeutic conjugates inhibiting vascular smooth muscle cells
10/08/2003EP1350521A1 Immunotherapeutic combinations for the treatment of tumors
10/08/2003EP1350509A1 Mucosal immunomodulator and use thereof
10/08/2003EP1350262A2 Cpg-like nucleic acids and methods of use thereof
10/08/2003EP1350113A2 Inhibition of cmv infection and dissemination
10/08/2003EP1350085A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
10/08/2003EP1349936A2 Regulation of human b7-h2 protein
10/08/2003EP1349932A2 Novel human secreted proteins and polynucleotides encoding the same
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349925A2 Functional balanced-lethal host-vector systems
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349871A2 Novel marker for the diagnosis and therapy of tumours
10/08/2003EP1349870A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1349868A1 Process to concentrate insoluble proteins by vibrating membrane filtration
10/08/2003EP1349577A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
10/08/2003EP1349574A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
10/08/2003EP1349573A1 Collectins as adjuvants
10/08/2003EP1349572A1 Manufacturing method of combined vaccine
10/08/2003EP1349570A1 ENTEROHEMORRAGIC i ESCHERICHIA COLI /i VACCINE
10/08/2003EP1349568A1 Immunomodulatory constructs and their uses
10/08/2003EP1349567A1 Compositions containing gangliosides for use in the treatment of skin disorders
10/08/2003EP1349485A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1227808B1 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
10/08/2003EP1073455B1 Compositions and methods for extending the action of clostridial neurotoxin
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0865448B1 Apoptosis induced by monoclonal antibody anti-her2
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003EP0551460B2 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV)
10/08/2003CN1447919A Use of antibodies against specific MHC-Peptide complexes
10/08/2003CN1447857A Agonist anti-TRK-C monoclonal antibodies
10/08/2003CN1447696A Gene detection assay for improving likelihood of effective response to erbb antagonist cancer therapy
10/08/2003CN1446583A Composition, preparation and application scheme of tumor immunological therapy and preventative vaccine
10/08/2003CN1446581A Coupling object between CB and biological active peptide or immunoglobhulin or immunological activity original as well as medication usage
10/07/2003US6630582 Isolated nucleic acid, of given sequence, which encodes a catalase; gastroduodenal diseases
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630480 Methods of treating leukemia
10/07/2003US6630455 Methods for inducing mucosal immune responses
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630443 Detecting agonists and antagonists; treating under- and overexpression
10/07/2003US6630350 Monoclonal antibodies against a human act and serine protease complex
10/07/2003US6630343 Hepatitis C virus culture system
1 ... 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 ... 1823